Patents by Inventor Chris Neff
Chris Neff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140113310Abstract: Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided.Type: ApplicationFiled: June 6, 2011Publication date: April 24, 2014Applicant: Myriad Genetics, IncorporatedInventors: Mark Skolnick, Jerry Lanchbury, Kirsten Timms, Chris Neff, Ryan Hoff, Hubert Wang, Susanne Wagner, Zaina Sangale
-
Publication number: 20120309018Abstract: Methods and compositions involving molecular markers for the detection and characterization of cancer in a patient are provided.Type: ApplicationFiled: June 6, 2011Publication date: December 6, 2012Applicant: Myriad Genetics, IncorporatedInventors: Mark Skolnick, Jerry Lanchbury, Kirsten Timms, Chris Neff, Ryan Hoff, Hubert Wang, Susanne Wagner, Zaina Sangale
-
Patent number: 7572905Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.Type: GrantFiled: October 23, 2007Date of Patent: August 11, 2009Assignee: Myriad Genetics, Inc.Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff
-
Patent number: 7544475Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.Type: GrantFiled: May 17, 2007Date of Patent: June 9, 2009Assignee: IHC Health Services, Inc.Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff, Lisa Cannon-Albright, Nicola Camp
-
Patent number: 7410944Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.Type: GrantFiled: May 26, 2006Date of Patent: August 12, 2008Assignee: Myriad Genetics, Inc.Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff
-
Publication number: 20080160519Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.Type: ApplicationFiled: May 17, 2007Publication date: July 3, 2008Applicant: Intermountain Health Care, Inc.Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff, Lisa Cannon-Albright, Nicola Camp
-
Patent number: 7052853Abstract: The present invention relates generally to the field of human genetics. Specifically, the present invention relates to methods and materials used to isolate and detect a human depression predisposing gene, specifically the apoptotic protease activating factor 1 (APAF1) gene, some mutant alleles of which cause susceptibility to depression. More specifically, the invention relates to germline mutations in the APAF1 gene and their use in the diagnosis of predisposition to depression. The invention also relates to the prophylaxis and/or therapy of depression associated with a mutation in the APAF1 gene. The invention further relates to the screening of drugs for depression therapy. Finally, the invention relates to the screening of the APAF1 gene for mutations/alterations, which are useful for diagnosing the predisposition to depression.Type: GrantFiled: August 21, 2003Date of Patent: May 30, 2006Assignee: Myriad Genetics, Inc.Inventors: Donna Shattuck, Deanna Russell, Victor Abkevich, Chris Neff
-
Patent number: 5915794Abstract: A simple sturdy multiply adjustable hand scraper has a knurled cross handle mounted on a shaft and an obliquely mounted blade on the other end of the shaft, the handle being adjustably set at an angle relative to the blade.Type: GrantFiled: January 27, 1998Date of Patent: June 29, 1999Assignee: Designer Floors, Inc.Inventor: Chris Neff